药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trilostane
Lofepramine
The risk or severity of hypertension can be increased when Lofepramine is combined with Indacaterol.
Trilostane
Melitracen
The risk or severity of hypertension can be increased when Melitracen is combined with Indacaterol.
Trilostane
Quinupramine
The risk or severity of hypertension can be increased when Quinupramine is combined with Indacaterol.
Trilostane
Dibenzepin
The risk or severity of hypertension can be increased when Dibenzepin is combined with Indacaterol.
Trilostane
Amitriptylinoxide
The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Indacaterol.
Trilostane
Opipramol
The risk or severity of hypertension can be increased when Opipramol is combined with Indacaterol.
Trilostane
Oxaprotiline
The risk or severity of hypertension can be increased when Oxaprotiline is combined with Indacaterol.
Trilostane
Dosulepin
The risk or severity of hypertension can be increased when Dosulepin is combined with Indacaterol.
Trilostane
Dimetacrine
The risk or severity of hypertension can be increased when Dimetacrine is combined with Indacaterol.
Trilostane
Amineptine
The risk or severity of hypertension can be increased when Amineptine is combined with Indacaterol.
Trilostane
Aripiprazole lauroxil
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Aripiprazole lauroxil.
Trilostane
Urapidil
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Urapidil.
Trilostane
Propiverine
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Propiverine.
Trilostane
Bunazosin
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Bunazosin.
Trilostane
Trimazosin
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Trimazosin.
Trilostane
Brexpiprazole
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Brexpiprazole.
Trilostane
Indoramin
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Indoramin.
Trilostane
Silodosin
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Silodosin.
Trilostane
Pizotifen
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Pizotifen.
Trilostane
Thioproperazine
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Thioproperazine.